KIT and neoplasm: The proangiogenic factors synthesized and released by the mast cells thus contribute to tumor angiogenesis.[29] Animal models have demonstrated that anti-SCF and anti-c-Kit antibodies reduce tumor infiltration of marrow-originated mast cells, indicating that mast cell migration is regulated by the SCF/c-Kit axis.